154 related articles for article (PubMed ID: 34396820)
1. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
He J
J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
[TBL] [Abstract][Full Text] [Related]
2. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
[TBL] [Abstract][Full Text] [Related]
3. Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change.
Bertoglio S
J Vasc Access; 2021 Sep; 22(5):689-691. PubMed ID: 32962527
[TBL] [Abstract][Full Text] [Related]
4. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
[TBL] [Abstract][Full Text] [Related]
5. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
8. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
[TBL] [Abstract][Full Text] [Related]
9. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
11. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
[TBL] [Abstract][Full Text] [Related]
12. Difficult removal of totally implantable venous access devices in adult patients: Incidence, risk factors, and management.
Chatani S; Tsukii R; Nagasawa K; Hasegawa T; Murata S; Kato M; Yamaura H; Onaya H; Matsuo K; Watanabe Y; Inaba Y
J Vasc Access; 2023 Sep; 24(5):1150-1157. PubMed ID: 35081814
[TBL] [Abstract][Full Text] [Related]
13. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
[TBL] [Abstract][Full Text] [Related]
15. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
[TBL] [Abstract][Full Text] [Related]
16. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
Choksi A; Finnegan K; Etezadi V
Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
[TBL] [Abstract][Full Text] [Related]
17. Infection of totally implantable venous access devices: A review of the literature.
Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
[TBL] [Abstract][Full Text] [Related]
18. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
Kim JT; Oh TY; Chang WH; Jeong YK
Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of totally implantable venous access devices.
Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
[TBL] [Abstract][Full Text] [Related]
20. Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.
Toro A; Schembari E; Fontana EG; Di Saverio S; Di Carlo I
Langenbecks Arch Surg; 2021 Sep; 406(6):1739-1749. PubMed ID: 34109472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
